Amb. Mailu was, in 1995, key in the conceptualization of the Health sector reforms in the Public Health sector in Kenya and more recently, contributed in laying the framework and foundation for the realization of the Sustainable Development Goals having been instrumental in identification of Universal Health Coverage as a national priority agenda for the Government of Kenya for the next four years. He championed the establishment of the SDG Platform Kenya; a forum to optimize synergies to build on existing partnerships and facilitate scaling up of Public Private Partnership around flagship programs in Kenya to leverage and complement ongoing and planned investments by the national and county governments.

Earlier in his career, Amb. Mailu practiced as a Clinical Geneticist; and worked in key management positions including: Manager Casualty/Emergency Medicine; Quality Assurance Manager; Manager Kenya Expanded Programme on Immunisation (EPI); Director, Division of Family Health that is responsible for maternal health, family planning and child health among others; Director, National Health Sector Reform Programme (1996-99). Dr. Mailu also contributed to Global Health having worked on many assignments as Project Officer for UNICEF India Country Office and Consultant for UNICEF/NY-HQ and WHO/Geneva.

Amb. Mailu has in his extensive career served in diverse Boards and councils in health, banking, education and labour sectors including Kenya coordinating mechanism on Global Fund. He served as the Chairman of Federation of Kenya Employers (FKE); Chairman, Machakos University College; Director, Kenya Private Sector Alliance (KEPSA); Trustee, National Social Security Fund (NSSF); and Member, National Aids Control Council (NACC) among others.

Over this period Amb. Mailu received several commendations and honours from H.E. The President of the Republic of Kenya as well as Professional bodies.

Amb. Dr. Cleopa Mailu is a qualified medical doctor (MB,CHB;1984, University of Nairobi; Msc. Med. Science (Genetics), University of Glasgow, UK) with special interest in Clinical Genetics and In-Situ hybridization. He has extensive experience in strategy and policy formulation; organizational re- engineering and development; medical Audit and corporate governance.